AAO 2024: Alfredo Sadun on the aging ophthalmologist
November 2nd 2024Alfredo Sadun, MD, PhD, is the chief of Ophthalmology at the Doheny Eye Institute of UCLA. At this year's AAO meeting held in Chicago, Illinois, he stopped by the Eye Care Network booth to share insights from the symposium "Professional Longevity 2.0: Assessing the Ophthalmologist," which he presented during.
AAO 2024: Ocular imaging in the emergency department can provide timely, accurate diagnosis
November 1st 2024Victoria Biousse, MD, from the Emory University in Atlanta, Georgia, shared insights on how ocular imaging in the emergency department can provide timely, accurate diagnosis while also benefiting the on-call ophthalmologists. She shared these thoughts at this year's AAO meeting held in Chicago, Illinois.
AAO 2024: The role of MIGS in earlier intervention and safer techniques
October 28th 2024Vikas Chopra, MD, led a course on minimally invasive glaucoma surgery (MIGS) and its impact on glaucoma care. He explained that MIGS enables ophthalmologists to intervene earlier and more safely, which can lead to better outcomes for patients.
AAO 2024: New data and studies in glaucoma
October 27th 2024Victoria L Tseng, MD, PhD, assistant professor of ophthalmology and a glaucoma specialist at UCLA and scientist at Doheny Eye Institute, spoke with the Eye Care Network at this year's AAO meeting about the "Glaucoma Original Papers" session and discussed the papers presented in the session by Giovanni Montesano, MD; Jason D Horowitz, MD; Christopher M Edwards, BS; Eamonn Thomas Fahy, BMBCH; Kiana Tavakoli, MD; Hani El Helwe, MD; and Joseph F Panarelli, MD.
AAO 2024: Risk factors for complications of epithelium-off cross-linking
October 25th 2024Weijie Violet Lin, MD, presented findings from her research, which revealed that post-cross-linking complications were low and highlighted key risk factors and the importance of early identification to enhance long-term patient outcomes.
AAO 2024: Detail outlined for Artificial Intelligence Innovation Center at Wilmer Eye Institute
October 24th 2024During a conversation at the American Academy of Ophthalmology annual meeting in Chicago, T.Y. Alvin Liu, MD, discussed plans for the James P. Gills Jr., MD, & Heather Gills Artificial Intelligence Innovation Center at the Wilmer Eye Institute at Johns Hopkins Medicine.
AAO 2024: Ophthalmic drop wastage due to artificial expiration date
October 23rd 2024In a paper presented at the American Academy of Ophthalmology annual meeting in Chicago, Jonathan Tan, a third year medical student at the Icahn School of Medicine at Mount Sinai detailed the study on ophthalmic eye drop waste in clinics, revealing 72% medication loss due to outdated 28-day expiration guidelines, resulting in significant financial waste. The study advocates following FDA expiration dates.
AAO 2024: Chloroprocaine ophthalmic gel as anesthesia for intravitreal injections
October 23rd 2024Michael Singer, MD, shared insights from his experience using a preservative-free, chloroprocaine ophthalmic gel as anesthesia for intravitreal injections and the results of research on the effectiveness of gel versus traditional drops.
AAO 2024: Applying large language models in revenue cycle management
October 23rd 2024In a presentation at the American Academy of Ophthalmology’s annual meeting in Chicago, T.Y. Alvin Lu, MD, a retina specialist at Johns Hopkins Medicine, discussed the application of large language models (LLMs) in revenue cycle management (RCM).
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 23rd 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.
AAO 2024: New study shows promise for MICE procedure in treating corneal neovascularization
October 22nd 2024Kamran Riaz, MD, discussed with the Eye Care Network a study on mitomycin intravascular chemoembolization for treating corneal neovascularization. The procedure showed promise, with a 70% success rate at 3 to 6 months, though patient selection is crucial. Some required multiple treatments, but overall outcomes are promising.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 22nd 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: New drug shows promise as first to protect vision in patients with dry AMD
October 21st 2024According to a study presented at the American Academy of Ophthalmology’s annual meeting in Chicago, investigational treatment reduced vision loss and protected key structures in the eye essential for vision.
AAO 2024: Gildeuretinol and Stargardt disease: The TEASE program
October 20th 2024Christine Kay, MD sat down to discuss her presentation on gildeuretinol and its slowing of progression of Stargardt disease, studied in the TEASE program at this year's American Academy of Ophthalmology meeting held in Chicago, Illinois.
AAO 2024: 3D printed eyeglasses bring vision care to children in underserved, remote communities
October 20th 2024According to a presentation at the American Academy of Ophthalmology’s annual meeting in Chicago, a new study shows customized eyeglasses successfully addressed children’s complex eye needs.